Active Research Protocols

  1. 01-C-0091 – Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors
  2. 06-C-0227 – Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies
  3. 07-C-0040 – A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors
  4. 07-C-0206 – A Pilot Study of Tumor Vaccination and R-hIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors
  5. 08-C-0007 – A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer
  6. 09-C-0242 – Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
  7. 10-C-0086 – Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
  8. 10-C-0178 – A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma
  9. 10-C-0220 РPhase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo¨ (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Refractory Cancer
  10. 11-C-0073 – A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias
  11. 11-C-0159 – A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
  12. 12-C-0208 – Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients with Relapsed or Refractory Solid Tumors
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014